{"corpus_id":4835237,"paper_sha":"3b09cf3b8cc59b5d16c4717c50ffa70edb467046","doi":"10.1002/ppul.23304","arxiv_id":null,"pmid":26418604,"pmcid":"4912005","mag_id":2725075505,"dblp_id":null,"acl_id":null,"title":"Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review","year":2015,"publication_date":"2015-09-29","venue":"Pediatric Pulmonology","journal":{"name":"Pediatric Pulmonology","pages":"115 - 132","volume":"51"},"journal_issn":null,"journal_title":null,"publication_types":["Review","JournalArticle"],"pubmed_pub_types":["Consensus Statement","Journal Article","Practice Guideline","Research Support, N.I.H., Extramural","Research Support, N.I.H., Intramural","Review"],"s2_fields_of_study":["Medicine"],"reference_count":172,"citation_count":362,"influential_citation_count":20,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Biopsy","mj":false,"ui":"D001706"},{"d":"Breath Tests","mj":false,"ui":"D001944"},{"d":"Chronic Disease","mj":false,"ui":"D002908"},{"d":"Disease Management","mj":false,"ui":"D019468"},{"d":"Genetic Testing","mj":false,"ui":"D005820"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Influenza Vaccines","mj":false,"qs":[{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D007252"},{"d":"Kartagener Syndrome","mj":false,"qs":[{"q":"diagnosis","mj":true,"ui":"Q000175"},{"q":"therapy","mj":true,"ui":"Q000628"}],"ui":"D007619"},{"d":"Microscopy, Electron","mj":false,"ui":"D008854"},{"d":"Microscopy, Video","mj":false,"ui":"D018715"},{"d":"North America","mj":false,"ui":"D009656"},{"d":"Pneumococcal Vaccines","mj":false,"qs":[{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D022242"},{"d":"Respiratory Syncytial Virus Vaccines","mj":false,"qs":[{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D022261"},{"d":"Respiratory Therapy","mj":false,"qs":[{"q":"methods","mj":false,"ui":"Q000379"}],"ui":"D012138"}],"chemicals":[{"n":"Influenza Vaccines","ui":"D007252","reg":"0"},{"n":"Pneumococcal Vaccines","ui":"D022242","reg":"0"},{"n":"Respiratory Syncytial Virus Vaccines","ui":"D022261","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ppul.23304","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/3b09cf3b8cc59b5d16c4717c50ffa70edb467046","s2_open_access_license":"CCBYNCND","s2_open_access_status":"HYBRID","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, rare lung disease resulting in chronic oto‐sino‐pulmonary disease in both children and adults. Many physicians incorrectly diagnose PCD or eliminate PCD from their differential diagnosis due to inexperience with diagnostic testing methods. Thus far, all therapies used for PCD are unproven through large clinical trials. This review article outlines consensus recommendations from PCD physicians in North America who have been engaged in a PCD centered research consortium for the last 10 years. These recommendations have been adopted by the governing board of the PCD Foundation to provide guidance for PCD clinical centers for diagnostic testing, monitoring, and appropriate short and long‐term therapeutics in PCD patients. Pediatr Pulmonol. 2016;51:115–132. © 2015 The Authors. Pediatric Pulmonology Published by Wiley Periodicals, Inc.","claims":[{"public_id":"cl_c975fc7781c80bd71c64cb8c56b2b964","status":"active","text":"Consensus recommendations are provided to guide PCD clinical centers in diagnostic testing, monitoring, and short- and long-term therapeutics.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_c975fc7781c80bd71c64cb8c56b2b964"},{"public_id":"cl_47462c5c624e764ab4963ec0f30c15f6","status":"active","text":"Large clinical trials have not yet proven the therapies used for PCD.","confidence":0.94,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_47462c5c624e764ab4963ec0f30c15f6"},{"public_id":"cl_7972f09a021d3e222dcab5fceb188be0","status":"active","text":"The recommendations are based on a state-of-the-art review by North American physicians involved in a PCD research consortium over the last 10 years.","confidence":0.9,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_7972f09a021d3e222dcab5fceb188be0"},{"public_id":"cl_adab92e4900c0a605d55b5e35aa2fd41","status":"active","text":"The recommendations were adopted by the PCD Foundation governing board.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_adab92e4900c0a605d55b5e35aa2fd41"}],"concepts":[{"public_id":"co_0a77f26adf4ed966f72cd45b23484abb","status":"active","name":"PCD research consortium","description":"A research collaboration focused on primary ciliary dyskinesia over a 10-year period.","types":["research consortium"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_0a77f26adf4ed966f72cd45b23484abb"},{"public_id":"co_44278d756467b7d5b4df56ac405825f8","status":"active","name":"primary ciliary dyskinesia","description":"A genetically heterogeneous rare lung disease that causes chronic oto-sino-pulmonary disease.","types":["disease"],"aliases":["PCD"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_44278d756467b7d5b4df56ac405825f8"},{"public_id":"co_493686f405cf4f7628f418c147a3a2e8","status":"active","name":"large clinical trials","description":"Substantial clinical studies used to evaluate the effectiveness of therapies.","types":["study design"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_493686f405cf4f7628f418c147a3a2e8"},{"public_id":"co_4e5a2ab6a79f2528f5baf31ec7f6852e","status":"active","name":"PCD Foundation","description":"The professional foundation whose governing board adopted the recommendations.","types":["organization"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_4e5a2ab6a79f2528f5baf31ec7f6852e"},{"public_id":"co_63f5d318999a76fc369e6b0862cb6777","status":"active","name":"therapies used for PCD","description":"Treatments used in primary ciliary dyskinesia care, including short- and long-term therapeutic approaches.","types":["treatment"],"aliases":["therapies used for primary ciliary dyskinesia"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_63f5d318999a76fc369e6b0862cb6777"},{"public_id":"co_6b8b89801eddc468162959387c754971","status":"active","name":"state-of-the-art review","description":"A comprehensive review of current evidence used as the basis for the recommendations.","types":["review"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6b8b89801eddc468162959387c754971"},{"public_id":"co_7aac526b1b6cd02c7858a30b996277fe","status":"active","name":"diagnostic testing","description":"Testing procedures used to establish or confirm a diagnosis of primary ciliary dyskinesia.","types":["clinical procedure"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7aac526b1b6cd02c7858a30b996277fe"},{"public_id":"co_948b4fb018af5eee58c37f11d2e1fae7","status":"active","name":"North American physicians","description":"Physicians from North America involved in developing the recommendations.","types":["person group"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_948b4fb018af5eee58c37f11d2e1fae7"},{"public_id":"co_972e0d7e65d6fb2e9e08767e8c98c9ab","status":"active","name":"monitoring","description":"Ongoing clinical follow-up used to assess disease status in patients with primary ciliary dyskinesia.","types":["clinical management"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_972e0d7e65d6fb2e9e08767e8c98c9ab"},{"public_id":"co_c6b42e7d95a8122b9492f24fb0b1eb37","status":"active","name":"PCD Foundation consensus recommendations","description":"A set of clinical recommendations for the diagnosis, monitoring, and treatment of primary ciliary dyskinesia.","types":["guideline"],"aliases":["consensus recommendations"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c6b42e7d95a8122b9492f24fb0b1eb37"}],"external_ids":{"DOI":"10.1002/ppul.23304","ArXiv":null,"PubMed":26418604,"PubMedCentral":"4912005","MAG":2725075505,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ppul.23304","landing_url":"https://www.semanticscholar.org/paper/3b09cf3b8cc59b5d16c4717c50ffa70edb467046","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBYNCND","status":"HYBRID","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":634139,"paper_uid":"4028afd2-139f-46d9-847e-b558af1125b7","canonical_identity":{"paper_id":634139,"paper_uid":"4028afd2-139f-46d9-847e-b558af1125b7","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/4835237"}